Funder
Univerzita Karlova v Praze
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference22 articles.
1. Daugirdas J, Blake P, Ing T (2015) Handbook of dialysis. Wolters Kluwer
2. Haase M, Bellomo R, Rocktaeschel J, Ziemer S, Kiesewetter H, Morgera S, Neumayer HH (2005) Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II. Nephrol Dial Transplant 20(2):444–446. https://doi.org/10.1093/ndt/gfh544
3. Brown P, Jay R, Fox A, Oliver M (2013) Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature. Hemodial Int 17(3):444–449. https://doi.org/10.1111/hdi.12003
4. Taskapan H, Karahan D, Kuku I, Koc S (2010) Heparin-induced thrombocytopenia as a cause of deep venous thrombosis: effectiveness of fondaparinux in dialysis patients. Turkish Nephrology Dialysis Transplantation 19:55–57. https://doi.org/10.5262/tndt.2010.1001.09
5. European Medicines Agency (2021) (https://www.ema.europa.eu/en/medicines/human/EPAR/arixtra#product-information-section, accessed 06/23/2021) Arixtra: Summary of Product Characteristics
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献